SLC6A1 and epilepsy: Considering the different therapeutic response between Slc6a1+/– and Slc6a1–/– mice, our results suggest that for the epilepsy phenotype, the complete loss of SLC6A1 function creates more severe and potentially irreversible changes in brain circuitry beyond very early mouse postnatal periods.